Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Aeris Resources marks June quarter as best in FY2018

2018-07-18 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) achieved copper production for the June quarter of 7,592 tonnes, an 11% increase on the previous quarter and the best quarter for FY2018.
ARSRF AIS

0
Aeris Resources identifies 28 anomalies at Torrens Copper-Gold Project

2018-07-17 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has identified 28 anomalies from airborne gravity surveys at its Torrens project in South Australia.
ARSRF AIS AGREF ARE

0
Argonaut Resources identifies iron oxide copper-gold targets at Torrens project

2018-07-16 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has identified 28 large volume iron oxide copper-gold (IOCG) drilling targets from airborne gravity and magnetic survey data of the Torrens exploration licence in South Australia.
ARSRF AIS AGREF ARE

0
Argonaut Resources NL identifies iron oxide copper-gold targets at Torrens project

2018-07-16 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has identified 28 large volume iron oxide copper-gold (IOCG) drilling targets from airborne gravity and magnetic survey data of the Torrens exploration licence in South Australia.
ARSRF AIS AGREF ARE

0
Loadscan’s guide to optimising payloads

2018-07-11 australianmining.com.au
To achieve optimal mine productivity Loadscan urges operators to properly understand if they are moving the maximum amount of material as efficiently as possible, shift after shift.
ARSRF AIS

0
METS Ignited awards more cash to supply companies

2018-07-05 australianmining.com.au
Eight mining equipment, technology and services (METS) companies have received a total of $7.14 million as part of the Department of Industry, Innovation and Science’s four-year, $15.6 million commitment to address METS sector priorities.
ARSRF AIS AAUKF AAL NGLOY

0
Aeris Resources’ drilling expands potential for copper production at Tritton

2018-06-12 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has received highly encouraging results from three drill holes at the Kurrajong Prospect, part of its Tritton tenement package in New South Wales.
ARSRF AIS

0
Aeris Resources hits 20 metre semi-massive copper sulphide zone

2018-05-16 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has intersected a 20-metre thick massive and semi-massive sulphide at its Kurrajong prospect within the Tritton tenements in New South Wales.
ARSRF AIS

0
Aeris Resources hits 20 metres semi-massive copper sulphide zone

2018-05-16 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has intersected a 20-metre thick massive and semi-massive sulphide at its Kurrajong prospect within the Tritton tenements in New South Wales.
ARSRF AIS

0
Aeris Resources puts pedal to the metal with robust financial position providing growth

2018-05-01 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) is poised to finish fiscal 2018 on a high, recently confirming that it was on track to meet annual copper production guidance of 27,000 tonnes.
ARSRF AIS AGREF ARE

0
Aeris Resources increases copper production in March quarter

2018-04-26 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) increased quarterly copper production by 6.2% to 6,867 tonnes of copper from its 100% owned Tritton Copper Operations in central-west New South Wales.
ARSRF AIS

0
Argonaut Resources has market's attention with Olympic Dam style target

2018-03-20 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has an expansive project portfolio prospective for copper, cobalt, lithium and gold across Australia and Zambia in Africa.
ARSRF AIS AGREF ARE

0
Argonaut Resources has markets attention with Olympic Dam style target

2018-03-20 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has an expansive project portfolio prospective for copper, cobalt, lithium and gold across Australia and Zambia in Africa.
ARSRF AIS AGREF ARE

0
Aeris Resources has potential to strengthen its copper portfolio following go-ahead for Lake Torrens

2018-03-19 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) is a beneficiary of a federal court ruling which dismissed appeals by three groups relating to the proposed Lake Torrens project in South Australia.
ARSRF AIS AGREF ARE

0
Argonaut Resources confirms favourable court decision for Lake Torrens title rights

2018-03-19 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) is getting ready to resume drilling at the Torrens joint venture near Olympic Dam in South Australia, following a favourable decision by the full federal court.
ARSRF AIS AGREF ARE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:AIS / AERIS RESOURCES LIMITED on message board site Silicon Investor.

Kaiser Bottom Fishes new CA travel approval policy raises concerns
Companhia Energetica de Minas Gerais -- CEMIG Renaisance u0026 Husky Merger
Genaissance Pharmaceuticals (GNSC) RNR - RenaissanceRe Holdings
KAISERu0027 PICKS AND FAX ALERTS, ***(JOHN KAISER) URUGUAY, en Espa��ol. Pais Peligroso.
RENN: Renaissance Cap. Growth KLU: Kaiser Aluminum Corp.